TY - JOUR
T1 - Anomalous left coronary artery fromthe pulmonary artery in infants and toddlers misdiagnosed as myocarditis
AU - Levitas, Aaviva
AU - Krymko, Hana
AU - Ioffe, Viktoriya
AU - Zalzstein, Eliyahu
AU - Broides, Arnon
N1 - Publisher Copyright:
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Objectives: Anomalous left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital heart defect. Children with this anomaly are usually asymptomatic at birth and develop symptoms later on in life, which may mimic myocarditis.We sought to delineate clinical, laboratory, and epidemiological aspects of this anomaly. Methods: A retrospective analysis of children with ALCAPA evaluated in a tertiary medical center in southern Israel was performed. A computerized search for all patients with the diagnosis of ALCAPA between 2000 and 2011 was performed. The medical records were reviewed; demographic, clinical, and laboratory data were extracted. Results: A total of 9 patients were included. In 4 patients, acute deterioration required evaluation in the pediatric emergencymedicine department; in all 4, the initial clinical suspicion was myocarditis. Failure to thrive was recorded in 7 (77.7%) of the 9 patients and asthma or wheezing were recorded in 5 (55.5%) of the 9 patients. Normal heart size was recorded in 4 (44.4%) of the 9 patients. Electrocardiographic abnormalities were present in all of the patients (100%). A total of 141,675 births were recorded during the study period, giving an incidence of at least 1 case (0.00635%) per 15,741 births. Conclusions: Children evaluated in the emergency medicine department with suspected myocarditis should be evaluated specifically for ALCAPA. The clinical findings that should raise the suspicion of this anomaly are failure to thrive and either a diagnosis of asthma or recurrent wheezing.
AB - Objectives: Anomalous left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital heart defect. Children with this anomaly are usually asymptomatic at birth and develop symptoms later on in life, which may mimic myocarditis.We sought to delineate clinical, laboratory, and epidemiological aspects of this anomaly. Methods: A retrospective analysis of children with ALCAPA evaluated in a tertiary medical center in southern Israel was performed. A computerized search for all patients with the diagnosis of ALCAPA between 2000 and 2011 was performed. The medical records were reviewed; demographic, clinical, and laboratory data were extracted. Results: A total of 9 patients were included. In 4 patients, acute deterioration required evaluation in the pediatric emergencymedicine department; in all 4, the initial clinical suspicion was myocarditis. Failure to thrive was recorded in 7 (77.7%) of the 9 patients and asthma or wheezing were recorded in 5 (55.5%) of the 9 patients. Normal heart size was recorded in 4 (44.4%) of the 9 patients. Electrocardiographic abnormalities were present in all of the patients (100%). A total of 141,675 births were recorded during the study period, giving an incidence of at least 1 case (0.00635%) per 15,741 births. Conclusions: Children evaluated in the emergency medicine department with suspected myocarditis should be evaluated specifically for ALCAPA. The clinical findings that should raise the suspicion of this anomaly are failure to thrive and either a diagnosis of asthma or recurrent wheezing.
KW - Coronary artery
KW - Failure to thrive
KW - Myocarditis
UR - http://www.scopus.com/inward/record.url?scp=84944339885&partnerID=8YFLogxK
U2 - 10.1097/PEC.0000000000000511
DO - 10.1097/PEC.0000000000000511
M3 - Article
C2 - 26414630
AN - SCOPUS:84944339885
SN - 0749-5161
VL - 32
SP - 232
EP - 234
JO - Pediatric Emergency Care
JF - Pediatric Emergency Care
IS - 4
ER -